Can plasma transfusion stop leptospirosis lung damage? new trial aims to find out

NCT ID NCT07127718

First seen Apr 20, 2026 · Last updated May 13, 2026 · Updated 4 times

Summary

This study tests whether a blood protein (CFI) can predict lung damage in people with leptospirosis, a bacterial infection. It also compares plasma transfusions and blood-filtering treatments to standard care to see if they prevent serious complications. About 678 participants will receive either standard therapy or these additional treatments. The goal is to reduce lung injury and improve survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOSPIROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Human Genetics, National Institutes of Health - University of the Philippines Manila

    ACTIVE_NOT_RECRUITING

    Manila, National Capital Region, 1000, Philippines

  • National Kidney and Transplant Institute

    RECRUITING

    Quezon City, National Capital Region, 1100, Philippines

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • San Lazaro Hospital

    RECRUITING

    Manila, National Capital Region, 1003, Philippines

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.